Methods and devices for vascular access

Information

  • Patent Grant
  • 11607525
  • Patent Number
    11,607,525
  • Date Filed
    Wednesday, July 13, 2022
    a year ago
  • Date Issued
    Tuesday, March 21, 2023
    a year ago
Abstract
A catheter assembly configured for use with a male luer is provided herein. The catheter assembly can comprise a catheter hub having an interior chamber and a valve located in the interior chamber. The valve can comprise a distal portion, a proximal portion, and a sidewall extending therebetween to define a valve interior. The valve can include a barrier layer having a concave shape that extends in the valve interior from the sidewall at the distal portion. The barrier layer can have at least one slit extending therethrough that is in a normally closed configuration to prevent a fluid from passing through the barrier layer. The catheter assembly can further comprise a sealing ring located circumferentially at a distal end of the valve distally to the barrier layer. The sealing ring can form a seal between the valve and the interior chamber at the distal end.
Description
FIELD OF THE INVENTION

The present disclosure is directed to valve assemblies having improved ability to selectively allow flow of fluids through the medical device and prevent leakage of fluids from the proximal end of the device. Such improved valve assemblies also prevent leakage of fluids after repeated insertion and removal of medical instruments through the valve, such as catheters, introducers, tubes, lines, and ports that can be used for vascular or other devices. The valve assemblies can also be used as a connection for needles (e.g., fistula needles), hemodialysis circuits, feeding tubes, urinary drain catheters, or any other suitable means.


BACKGROUND

Catheters allow medical practitioners to administer infusion or removal of fluids from a patient. For example, catheters can function as a conduit that allows infusion of fluids, such as normal saline solution, therapeutic substances, and/or nutritional fluids into a patient. Alternatively, catheters can withdraw fluids such as blood or other bodily fluids as required by the particular medical procedure. In those cases where the medical practitioner intends to position the catheter into a vessel, the medical practitioner will look for a flow of blood back into the catheter (“flashback”) to verify placement of the catheter opening into a vessel. The number of different catheter insertion procedures and techniques is great and may include the use of a needle, dilator, stylet, or other medical devices within the catheter when placed.


Once properly positioned, the catheter's hub (or medical device positioned within the catheter) can be coupled to an adapter (typically a luer fitting) to enable fluid coupling of the catheter to the source of fluids or reservoir. However, in the case of an accidental disconnection between the catheter and the reservoir, there is a possibility for the patient to bleed out or to entrain air that will lead to an embolism, both of which are potentially life-threatening for the patient. Accidental disconnection can occur if the mating parts are not securely tightened. The mating parts can also become loose from patient movement, unwanted fidgeting, or other patient interference. Further, if the patients have any blood-borne pathogen (e.g., HIV, hepatitis, etc.), blood exposure for the caregiver is potentially lethal. As such, insertion of the catheter requires that the point of access remains sanitary. The period between insertion of the catheter and coupling of an adaptor can cause bodily fluids to escape through the catheter, causing an unsanitary condition for the medical practitioner who must handle the catheter for coupling of the adapter and/or remove the medical device inserted through the catheter. The caregiver often covers an open connection port with their finger to reduce the blood flow until making a mating connection. Since blood can be a medium for bacterial growth, infection chances can rise due to exposure at the time of catheter insertion.


As such, there remains a need for a valve assembly that permits controlled fluid flow that also reduces risk of infection by providing a tight seal with respect to the catheter. There also remains a need for a valve that slows blood loss to give the caretaker time to adequately clean the connection and wipe away any residual blood on the connection. There also remains a need for a valve that minimizes the blood exposure for the caregiver at the time of insertion, removal, or a change in catheters.


SUMMARY

The illustrations and variations described herein are meant to provide examples of the methods and devices of the invention. It is contemplated that combinations of aspects of specific embodiments or combinations of the specific embodiments themselves are within the scope of this disclosure. The valve assemblies described herein can be used in any tubing assembly, especially medical tubing not only limited to catheter assemblies.


A catheter assembly configured for use with a male luer is provided. The catheter assembly can comprise a catheter hub having an interior chamber and a valve located in the interior chamber. The valve can comprise a distal portion, a proximal portion, and a sidewall extending therebetween to define a valve interior. The valve can include a barrier layer having an arcuate shape that extends in the valve interior from the sidewall at the distal portion. The barrier layer can have at least one slit extending therethrough that is in a normally closed configuration to prevent a fluid from passing through the barrier layer.


The catheter assembly can further comprise a sealing ring located circumferentially at a distal end of the valve distally to the barrier layer. The sealing ring can have an exterior sealing surface that forms a seal between the valve and the interior chamber at the distal end. An exterior diameter of the valve can be smallest at a recessed portion located between the sidewall and the barrier layer and proximally adjacent to the exterior sealing surface. The recessed portion can be configured to provide deformation of the valve. A thickness of the sidewall at the recessed portion can be less than a thickness of the barrier layer.


The catheter assembly can further comprise a protrusion on an exterior surface of the sidewall. The protrusion can be located proximally to the recessed portion. The protrusion can nest within an opening in the interior chamber such that upon insertion of the luer into the proximal portion of the valve, the protrusion reinforces an adjacent sidewall to reduce elastic deformation of the valve at the protrusion and causing increased outward elastic deformation of the sidewall at the recessed portion. Further distal advancement of the luer can cause elastic deformation of the barrier layer opening the at least one slit such that the fluid can pass through the barrier layer.


The sealing ring can comprise a rounded edge along a sealing ring circumference. A plurality of protrusions can be provided on the exterior surface of the sidewall. The plurality of protrusions can each couple with a plurality of openings within the interior chamber. A lubricant within the interior chamber can be further provided. The sealing ring can remain engaged with an inner surface of the chamber when the male luer engages the recessed portion. The valve can comprise a flange at a proximal end. The flange can engage with a proximal end of the catheter hub. A thickness of the sidewall can be less than the thickness of the barrier layer.


The present disclosure is related to the following commonly assigned patents and applications, the entirety of each of which is incorporated by reference: U.S. Pat. No. 11,324,939 issued on May 10, 2022; U.S. Pat. No. 8,105,288 issued on Jan. 31, 2012; U.S. Pat. No. 8,591,469 issued on Nov. 26, 2013; U.S. Pat. No. 9,775,973 issued on Oct. 3, 2017; U.S. Pat. No. 9,604,035 issued on Mar. 28, 2017; U.S. Pat. No. 10,828,465 issued on Nov. 10, 2020; U.S. publication nos.: US20200016375A1 published on Jan. 16, 2020, and US20210031009A1 published on Feb. 4, 2021; Provisional application Nos.: 62/993,493 filed on Mar. 23, 2020; 63/037,496 filed on Jun. 10, 2020; and 63/037,841 filed on Jun. 11, 2020.





BRIEF DESCRIPTION OF THE DRAWINGS

Each of the following figures diagrammatically illustrates aspects and variations to better understand the invention. Variation of the invention from the aspects shown in the figures is contemplated.



FIG. 1A shows a perspective view of a variation of an improved catheter-valve assembly.



FIG. 1B shows an exploded view of the assembly of FIG. 1A



FIG. 2A shows a perspective view of one variation of a valve.



FIG. 2B shows a top view of the valve of FIG. 2A.



FIG. 2C shows a side view of the valve of FIG. 2A.



FIG. 2D shows a front view of the valve of FIG. 2A.



FIG. 2E shows a rear view of the valve of FIG. 2A.



FIGS. 3A and 3B show cross-sectional side views of a catheter hub and the valve of FIG. 1A.



FIGS. 3C and 3D show cross-sectional side views of a catheter hub and the valve of FIG. 1A with a male luer introduced therein.



FIG. 4A shows a perspective view of another variation of an improved catheter-valve assembly.



FIG. 4B shows an exploded view of the assembly of FIG. 4A



FIG. 4C shows a perspective view of the valve of FIG. 4A.



FIG. 4D shows a side view of the valve of FIG. 4A.



FIG. 4E shows a cross-sectional side view of another variation of the catheter hub and the valve of FIG. 4A.



FIG. 4F shows a cross-sectional side view of another variation of the catheter hub and the valve of FIG. 4A with a male luer introduced therein.



FIGS. 4G and 4H show cross-sectional side views of a catheter hub and the valve of FIG. 4A with a male luer introduced therein.





DETAILED DESCRIPTION

For a better understanding of the present invention, reference will be made to the following description of the embodiments, which is to be read in association with the accompanying drawings, which are incorporated in and constitute a part of this specification, show certain aspects of the subject matter disclosed herein and, together with the description, help explain some of the principles associated with the disclosed implementations.


The terms “a” or “an”, as used herein, are defined as one or as more than one. The term “plurality”, as used herein, is defined as two or as more than two. The term “another”, as used herein, is defined as at least a second or more. The terms “including” and/or “having”, as used herein, are defined as comprising. (i.e., open language). The term “coupled”, as used herein, is defined as connected, although not necessarily directly, and not necessarily mechanically.


Reference throughout this document to “some embodiments”, “one embodiment”, “certain embodiments”, and “an embodiment” or similar terms means that a particular feature, structure, or characteristic described in connection with the embodiment is included in at least one embodiment of the present invention. Thus, the appearances of such phrases or in various places throughout this specification are not necessarily all referring to the same embodiment. Furthermore, the particular features, structures, or characteristics may be combined in any suitable manner in one or more embodiments without limitation.



FIG. 1A shows catheter-valve assembly 100 having a catheter hub 102, a valve 104, and a male luer 106 inserted therethrough. The catheter hub 102 can comprise a proximal end 108 and a distal end 110. A catheter tubing 112 can be coupled to the catheter and can extend from the distal end 110. As seen in FIG. 1B and further described herein, the valve 104 is seated in the open proximal end 108 of the catheter hub 102 so that the male luer 106 can then be inserted through a proximal end of the valve 104. The male luer 106 can be part of a medical device, such as a needle or other fluid source. As discussed below, the catheter hub 102 can include a pocket or hole 306 that nests protrusion 206 on the valve 104. The pocket 306 can extend partially within the catheter hub 102 or can extend through the catheter hub 102 forming a hole 306 as shown in FIGS. 1A and 1B.



FIGS. 2A to 2E show a valve having proximal end 200, distal end 202, and a sidewall 204 therebetween. In this variation, the sidewall can have protrusions 206 positioned on the outer surface of the valve 104. Protrusions 206 can be on either side of the sidewall 204 and can be circular, though other shapes can be considered. Additionally, the valve 104 can have a recessed portion 208 distal to the protrusions 206 and the sidewall 204. The recessed portion 208 is located where the valve 104 has its smallest exterior diameter and allows the valve 104 to deform when engaged by the male luer 106. While the figure shows two protrusions 104, any number of protrusions are within the scope of this disclosure.


The valve 104 includes a barrier layer 210 that extends from the sidewalls in an interior of the valve to prevent fluid flow. Variations of the valve 104 comprise barrier layers 210 that are opened through elastic deformation rather than pressure within the catheter assembly. For example, variations of the valves 104 require the male luer 106 to elastically deform the valve 104 and/or barrier layer 210 to permit fluid flow through the valve 104. In one additional variation, the barrier layer includes an arcuate or concave shape in an interior of the valve. The barrier layer 210 includes at least one slit 212 extending therethrough and has a normally closed configuration to prevent a fluid from passing therethrough the barrier layer 210. Alternatively, the barrier layer 210 can have a plurality of slits 212 that form a plurality of leaflet structures or flaps that open upon deformation of the valve 104.


The barrier layer 210 generally includes a flexible or semi-flexible material that is compatible with exposure to blood, medicaments, and other fluids commonly encountered during catheterization/infusion procedures. The valve 104 can be fabricated from a compliable and resilient material such that insertion of the male luer 106 causes the barrier layer 210 to stretch and deform to an open configuration.


In an additional variation, a distal end 202 of a valve 104 can have a sealing ring 214 located circumferentially around the valve and distally to the barrier layer 210. The sealing ring 214 can have an exterior sealing surface that forms a seal between the valve 104 and the hub 102 at the distal end 202 of the valve. The sealing ring 214 will be circumferentially engaged with the inner surface of the hub 102 such that the sealing ring 214 maintains a seal during insertion of the male luer 106, ensuring that fluid does not pass from the catheter hub 102 to an outer surface of valve 104. Variations of the valve can include a sealing ring 214 that is made of the same material as the remainder of the valve 104. Alternatively, the sealing ring 214 can comprise a different material than the remainder of the valve. Additionally, the angle at which the sealing ring 214 is offset with respect to the longitudinal axis can be changed to compress the valve 104 with respect to the hub 102 at varying diameters.


As seen in FIG. 3A, the catheter hub 102 has a chamber 300 extending from a proximal surface at the proximal end 108. The chamber 300 is in fluid communication with a catheter tubing 112 (FIGS. 1A and 1B) that is coupled to the hub 102. Variations of the chamber 300 can have straight walls or the walls can be tapered at an angle and can also have a tapered section 302 forming a female luer shape. The valve 104 exterior engages an inner surface 304 of the chamber 300 when the valve is inserted in the chamber, as seen in FIG. 3B. As shown in FIGS. 3B and 3C, the recessed portion 208 is offset from the inner surface 304 of the chamber 300. This offset in combination with the reinforcement of the valve wall adjacent to the protrusion 206 causes most of the deformation of the valve to occur at the recessed portion 208 of the wall distally to the protrusion.


Variations of the catheter hub 102 can comprise pockets or openings 306 positioned near the proximal end 108 of the hub 102, which seat the protrusions 206 of the valve 104 when the valve 104 is located in the chamber 300. Positioning of the valve 104 in the chamber 300 can occur via insertion or via molding of the valve into the chamber 300. As noted above, the protrusions 206 reinforce the sidewall 204 at the protrusions 206 to increase outward elastic deformation of the sidewall 204 at the recessed portion 208. The protrusions 206 nest in the openings 306 to hold the valve 104 in place such that the valve 104 to limit longitudinal stretching of the valve wall adjacent to the protrusion. This effect creates a preferential zone for stretching and/or deformation of the valve to open the barrier layer.


Protrusions 206 can additionally have a protrusion sealing ring that can provide additional interference along the openings 306. An outer portion of the protrusion where the protrusion 206 meets the edge of opening 306 accommodates the protrusion sealing ring. The protrusion sealing ring has a greater diameter than the remainder of the protrusion in order to provide a seal against the openings 306 of the hub 102. This seal, similar to sealing ring 214, prevents leaking of any fluid through the assembly.


Both the hub 102 and the valve 104 can comprise flanges, 216, 308 respectively, at their respective proximal ends that engage each other when the protrusions 206 nest within the openings 306. The valve flange portion 216 comprises a diameter greater than a diameter of the sidewall 204 for sealing against a proximal surface of the catheter hub flange 308. Alternatively, in some variations the valve flange portion 216 can include openings or segments such that it is not circumferentially continuous about the sidewall 204.


As seen in FIG. 3C, the male luer 106 is inserted into a valve interior 218 of the valve 104 and ultimately engages the walls/septum to elastically stretch the valve to open the barrier layer 210. The variations of the valve shown in FIG. 3C includes a valve interior 218 that is concave near the recessed portion 208 and includes walls with a tapered angle on the exterior and/or interior. During insertion, a distal end 310 of the male luer 106 can engage with the recessed portion 208 of the valve 104, as seen in FIG. 3D, causing the barrier layer 210 to open in a distal direction. Upon engagement and advancement of the luer, the barrier layer can undergo elastic deformation, opening the at least one slit 212 such that the fluid can pass through the barrier layer 210 and into a lumen 312 of the male luer 106. The valve interior 218 and male luer 106 can be provided with a small clearance therebetween to allow for easier longitudinal movement of the luer 106 within when the valve 104 diameter at the protrusions 206 decreases during insertion of the luer 106. In some variations, insertion of the male luer 106 into the valve interior 218 can cause the distal end of the barrier layer 210 to a fully open position, while the lateral surface of the male luer 106 engages the sidewall 204 of the valve 104. However, in alternate variations, the barrier layer 210 can merely deflect to allow sufficient fluid flow.


In additional variations of a valve, the thickness of the barrier layer 210 is greater than a thickness of the sidewall 204 at the recessed portion 208 as well as a thickness of the sidewall (excluding the regions where the protrusion 206 joins the sidewall). For example, the increased thickness of the barrier layer 210 permits the slit 212 to elastically return to a closed position once luer 106 is removed. The relatively thinner sidewall 204 reduces an offset distance between the internal diameter of the valve interior 218 and the inner surface 304 of chamber 300. Reducing this offset distance allows for insertion of the male luer 106 to a sufficient depth along a longitudinal axis to open the slit 212 at the barrier layer 210 of the valve 104 without being impeded by the sidewall 204 of the valve 104. For example, if the sidewall 204 is too thin, then the valve 104 can suffer from an increased risk of failure (e.g., cracking or splitting). The thickness of the barrier layer 210 increases relative rigidity in comparison with the remainder of the valve 104, allowing the slit 212 to close fully, increasing the likelihood that the slit returns to its original state to close the valve 104, preventing leakage. In some variations, the thickness differential also allows deformation of the valve to occur at the barrier layer rather than the sidewall or recessed portion 208.



FIGS. 4A to 4H show various views of another variation of a catheter-valve assembly. In this variation, the valve 104 can have one or more lips 400 on a proximal end 200. The lips 400 can engage with one or more recesses 402 on the catheter hub 102, as seen in FIGS. 4G and 4H. Upon engagement with the recesses 402, the lips 400 can overhang onto the recesses 402 on the hub 102 to secure the valve 104 onto the hub 102 for use with the male luer 106 or another medical device. In another variation of the device, threads 404 on the catheter hub 102 can be used to hold lips 400, preventing the valve 104 from being pushed in too far into the catheter hub 102.


Similar to the features in the variation shown in FIGS. 3A to 3D, the catheter hub 102 can have a chamber 300 extending from a proximal surface at the proximal end 108. The chamber 300 is in fluid communication with a catheter tubing 112 that is coupled to the hub 102. Variations of the chamber 300 can have straight walls or the walls can be tapered at an angle and can also have a tapered section 302 forming a female luer shape. The valve 104 exterior engages an inner surface 304 of the chamber 300 when the valve is inserted in the chamber, as seen in FIG. 4G. As shown in FIG. 4G, the recessed portion 208 is offset from the inner surface 304 of the chamber 300. This offset causes most of the deformation of the valve to occur at the recessed portion 208 of the wall.


As seen in FIGS. 4G and 4H, the male luer 106 is inserted into a valve interior 218 of the valve 104 and ultimately engages the walls/septum to elastically stretch the valve to open the barrier layer 210. The variations of the valve shown in FIGS. 4G and 4H includes a valve interior 218 that is concave near the recessed portion 208 and includes walls with a tapered angle on the exterior and/or interior. During insertion, a distal end 310 of the male luer 106 engages with the recessed portion 208 of the valve 104, as seen in FIG. 4H, causing the barrier layer 210 to open in a distal direction. Upon engagement and advancement of the luer, the barrier layer can undergo elastic deformation, opening the at least one slit 212 such that the fluid can pass through the barrier layer 210 and into a lumen 312 of the male luer 106. The valve interior 218 and male luer 106 can be provided with a small clearance therebetween to allow for easier longitudinal movement of the luer 106 within when the valve 104 diameter decreases during insertion of the luer 106. In some variations, insertion of the male luer 106 into the valve interior 218 can cause the distal end of the barrier layer 210 to a fully open position, while the lateral surface of the male luer 106 engages the sidewall 204 of the valve 104. However, in alternate variations, the barrier layer 210 can merely deflect to allow sufficient fluid flow.


In additional variations of a valve, the thickness of the barrier layer 210 is greater than a thickness of the sidewall 204 at the recessed portion 208 as well as a thickness of the sidewall. For example, the increased thickness of the barrier layer 210 permits the slit 212 to elastically return to a closed position once luer 106 is removed. The relatively thinner sidewall 204 reduces an offset distance between the internal diameter of the valve interior 218 and the inner surface 304 of chamber 300. Reducing this offset distance allows for insertion of the male luer 106 to a sufficient depth along a longitudinal axis to open the slit 212 at the barrier layer 210 of the valve 104 without being impeded by the sidewall 204 of the valve 104. For example, if the sidewall 204 is too thin, then the valve 104 can suffer from an increased risk of failure (e.g., cracking or splitting). The thickness of the barrier layer 210 can increase relative rigidity in comparison with the remainder of the valve 104, allowing the slit 212 to close fully, increasing the likelihood that the slit returns to its original state to close the valve 104, preventing leakage. In some variations, the thickness differential also allows deformation of the valve to occur at the barrier layer rather than the sidewall or recessed portion 208.


The previous description of the disclosed embodiments is provided to enable any person skilled in the art to make or use the present invention. Various modifications to these embodiments will be readily apparent to those skilled in the art, and the generic principles defined herein can be applied to other embodiments without departing from the spirit or scope of the invention. For example, a wide variety of materials may be chosen for the various components of the embodiments. It is therefore desired that the present embodiments be considered in all respects as illustrative and not restrictive, reference being made to the appended claims as well as the foregoing descriptions to indicate the scope of the invention.

Claims
  • 1. A catheter assembly configured for use with a medical device, the catheter assembly comprising: a catheter hub having an interior chamber;a valve located in the interior chamber and comprising a distal portion, a proximal portion, and a sidewall extending therebetween to define a valve interior, the valve including a barrier layer that extends in the valve interior from the sidewall at the distal portion, the barrier layer having at least one slit extending therethrough that is in a normally closed configuration to prevent a fluid from passing through the barrier layer;a sealing ring located circumferentially at a distal end of the valve distally to the barrier layer, the sealing ring having an exterior sealing surface that forms a seal between the valve and the interior chamber at the distal end, wherein an exterior diameter of the valve is smallest at a recessed portion located between the sidewall and the barrier layer and proximally adjacent to the exterior sealing surface, the recessed portion being configured to provide deformation of the valve, and where a thickness of the sidewall at the recessed portion is less than a thickness of the barrier layer; anda plurality of protrusions spaced apart on the exterior surface of the sidewall and spaced from a front and a back of the sidewall, wherein the plurality of protrusions each nest with a plurality of openings within the interior chamber, such that upon insertion of the medical device into the valve, the plurality of protrusions reinforce an adjacent sidewall to reduce elastic deformation of the adjacent sidewall causing increased elastic deformation of an un-reinforced portion of the sidewall, wherein further distal advancement of the medical device causes elastic deformation of the barrier layer to open the at least one slit.
  • 2. The catheter assembly of claim 1, wherein the sealing ring comprises a rounded edge along a sealing ring circumference.
  • 3. The catheter assembly of claim 1, further comprising a lubricant within the interior chamber.
  • 4. The catheter assembly of claim 1, wherein the sealing ring remains engaged with an inner surface of the chamber when the medical device engages the recessed portion.
  • 5. The catheter assembly of claim 1, where a thickness of the sidewall is less than the thickness of the barrier layer.
  • 6. The catheter assembly of claim 1, wherein the barrier layer has an arcuate shape.
  • 7. The catheter assembly of claim 1, wherein the plurality of protrusions are aligned with a longitudinal direction of the at least one slit.
  • 8. The catheter assembly of claim 1, further comprising a flange at the proximal portion of the valve, wherein the flange engages with a proximal end of the catheter hub.
  • 9. A catheter assembly configured for use with a medical device, the catheter assembly comprising: a catheter hub having an interior chamber;a valve located in the interior chamber and comprising a distal portion, a proximal portion, and a sidewall extending therebetween to define a valve interior, the valve including a barrier layer that extends in the valve interior from the sidewall at the distal portion, the barrier layer having at least one slit extending therethrough that is in a normally closed configuration to prevent a fluid from passing through the barrier layer, wherein an exterior diameter of the valve is smallest at a recessed portion located between the sidewall and the barrier layer, the recessed portion being configured to provide deformation of the valve, and where a thickness of the sidewall at the recessed portion is less than a thickness of the barrier layer; anda plurality of protrusions spaced apart on the exterior surface of the sidewall and spaced from a front and a back of the sidewall, wherein the plurality of protrusions each nest with a plurality of openings within the interior chamber, such that upon insertion of the medical device into the valve, the plurality of protrusions reinforce an adjacent sidewall to reduce elastic deformation of the adjacent sidewall causing increased elastic deformation of an un-reinforced portion of the sidewall, wherein further distal advancement of the medical device causes elastic deformation of the barrier layer to open the at least one slit.
  • 10. The catheter assembly of claim 9, further comprising a sealing ring located circumferentially at a distal end of the valve distally to the barrier layer, the sealing ring having an exterior sealing surface that forms a seal between the valve and the interior chamber at the distal end, wherein the sealing ring comprises a rounded edge along a sealing ring circumference.
  • 11. The catheter assembly of claim 10, wherein the sealing ring remains engaged with an inner surface of the chamber when the medical device engages the recessed portion.
  • 12. The catheter assembly of claim 9, further comprising a lubricant within the interior chamber.
  • 13. The catheter assembly of claim 9, wherein the barrier layer has an arcuate shape.
  • 14. The catheter assembly of claim 9, wherein the plurality of protrusions are aligned with a longitudinal direction of the at least one slit.
  • 15. The catheter assembly of claim 9, further comprising a flange at the proximal portion of the valve, wherein the flange engages with a proximal end of the catheter hub.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims priority to U.S. Patent Application No. 63/367,403 filed Jun. 30, 2022, the content of which is incorporated herein by reference in its entirety.

US Referenced Citations (162)
Number Name Date Kind
3195786 Vogt Jul 1965 A
3347232 Abraham Oct 1967 A
3356093 Monahon Dec 1967 A
3861416 Wichterle Jan 1975 A
4045009 Pees Aug 1977 A
4341239 Atkinson Jul 1982 A
4387879 Tauschinski Jun 1983 A
4465102 Rupp Aug 1984 A
4524805 Hoffman Jun 1985 A
4565545 Suzuki Jan 1986 A
4588398 Daugherty et al. May 1986 A
4629450 Suzuki et al. Dec 1986 A
4655752 Honkanen Apr 1987 A
4683916 Raines Aug 1987 A
4758225 Cox Jul 1988 A
4924923 Boehmer May 1990 A
4950257 Hibbs Aug 1990 A
5010925 Atkinson Apr 1991 A
5092857 Fleischhacker Mar 1992 A
5114407 Burbank May 1992 A
5114408 Fleischhaker May 1992 A
5122118 Haber et al. Jun 1992 A
5129884 Dysarz Jul 1992 A
5176650 Haining Jan 1993 A
5215538 Larkin Jun 1993 A
5242410 Melker Sep 1993 A
5269771 Thomas Dec 1993 A
5295658 Atkinson Mar 1994 A
5405323 Rogers Apr 1995 A
5445617 Yoon Aug 1995 A
5456284 Ryan Oct 1995 A
5462255 Rosen Oct 1995 A
5484418 Quiachon et al. Jan 1996 A
5527290 Zadini et al. Jun 1996 A
5533708 Atkinson Jul 1996 A
5618272 Nomura Apr 1997 A
5713876 Bogert et al. Feb 1998 A
5727594 Choksi Mar 1998 A
5843046 Motisi et al. Dec 1998 A
5871110 Grimard et al. Feb 1999 A
5957898 Jepson et al. Sep 1999 A
5967490 Pike Oct 1999 A
6024729 Dehdashtian et al. Feb 2000 A
6035896 Liardet Mar 2000 A
6142981 Heck Nov 2000 A
6165168 Russo Dec 2000 A
6168037 Grimard Jan 2001 B1
6186997 Gabbard et al. Feb 2001 B1
6261282 Jepson et al. Jul 2001 B1
6267748 Gulliksen et al. Jul 2001 B1
6352520 Miyazaki Mar 2002 B1
6390130 Guala May 2002 B1
6607511 Halseth et al. Aug 2003 B2
6702255 Dehdashtian Mar 2004 B2
6706017 Dulguerov Mar 2004 B1
6716197 Svendsen Apr 2004 B2
6817989 Svendsen et al. Nov 2004 B2
7001396 Glazier et al. Feb 2006 B2
7470254 Basta et al. Dec 2008 B2
7658725 Bialecki et al. Feb 2010 B2
7736339 Woehr et al. Jun 2010 B2
7736342 Abriles et al. Jun 2010 B2
7744571 Fisher et al. Jun 2010 B2
7753338 Desecki Jul 2010 B2
7892209 Harand et al. Feb 2011 B2
7914519 Moran et al. Mar 2011 B2
7938805 Harding et al. May 2011 B2
7947032 Harding et al. May 2011 B2
8006953 Bennett Aug 2011 B2
8021338 Adams Sep 2011 B2
8092432 Nordgren Jan 2012 B2
8105288 Keyser et al. Jan 2012 B2
8251923 Carrez et al. Aug 2012 B2
8361020 Stout Jan 2013 B2
8469928 Stout et al. Jun 2013 B2
8579870 Willis et al. Nov 2013 B2
8591469 Keyser et al. Nov 2013 B2
8647312 Utterberg et al. Feb 2014 B2
8758306 Lopez et al. Jun 2014 B2
8900192 Anderson et al. Dec 2014 B2
8915884 Tal et al. Dec 2014 B2
8932259 Stout et al. Jan 2015 B2
9028425 Burkholz May 2015 B2
9095683 Hall et al. Aug 2015 B2
9114231 Woehr et al. Aug 2015 B2
9149625 Woehr et al. Oct 2015 B2
9155863 Isaacson et al. Oct 2015 B2
9155864 Stout et al. Oct 2015 B2
9427549 Woehr et al. Aug 2016 B2
9604035 Keyser et al. Mar 2017 B2
9764117 Bierman et al. Sep 2017 B2
9775973 Keyser et al. Oct 2017 B2
9851268 Eichhorn et al. Dec 2017 B2
9861792 Hall et al. Jan 2018 B2
10004533 Entabi Jun 2018 B2
10010343 Bierman et al. Jul 2018 B2
10052474 Keyser et al. Aug 2018 B2
10136916 Bierman et al. Nov 2018 B2
10406326 Solomon Sep 2019 B2
10441752 Bierman et al. Oct 2019 B2
10569059 Bierman Feb 2020 B2
10682157 Bierman et al. Jun 2020 B2
10828465 Keyser et al. Nov 2020 B2
10850069 Solomon Dec 2020 B2
11318286 Sutton et al. May 2022 B2
11324939 Solomon et al. May 2022 B2
20040092879 Kraus et al. May 2004 A1
20040097880 Schur May 2004 A1
20040193109 Prestidge et al. Sep 2004 A1
20040193118 Bergeron Sep 2004 A1
20040236287 Swenson et al. Nov 2004 A1
20050131350 Shaw et al. Jun 2005 A1
20050187524 Willis et al. Aug 2005 A1
20050256460 Rome et al. Nov 2005 A1
20060200083 Freyman et al. Sep 2006 A1
20070161940 Blanchard Jul 2007 A1
20070225647 Luther et al. Sep 2007 A1
20070250037 Brimhall et al. Oct 2007 A1
20070270751 Stangenes et al. Nov 2007 A1
20070282268 Mayse Dec 2007 A1
20080015539 Pieroni et al. Jan 2008 A1
20080027389 Hiejima Jan 2008 A1
20080039802 Vangsness et al. Feb 2008 A1
20080092571 Allison et al. Apr 2008 A1
20080093571 Desecki Apr 2008 A1
20080108944 Woehr et al. May 2008 A1
20080172003 Plishka et al. Jul 2008 A1
20090209912 Keyser et al. Aug 2009 A1
20090209914 Koch et al. Aug 2009 A1
20090234290 Fisher et al. Sep 2009 A1
20090287154 Harding et al. Nov 2009 A1
20100331787 Fournie Dec 2010 A1
20110056569 Chambo et al. Mar 2011 A1
20110257590 Winsor et al. Oct 2011 A1
20120041371 Tal et al. Feb 2012 A1
20120150118 Keyser et al. Jun 2012 A1
20120221024 Sutton et al. Aug 2012 A1
20130204226 Keyser Aug 2013 A1
20140058357 Keyser et al. Feb 2014 A1
20140275795 Little et al. Sep 2014 A1
20140276432 Bierman et al. Sep 2014 A1
20150038910 Harding et al. Feb 2015 A1
20150148756 Lynn May 2015 A1
20150265827 Keyser et al. Sep 2015 A1
20150306368 Lin et al. Oct 2015 A1
20160228654 Rozwadowski et al. Aug 2016 A1
20160271370 Keyser et al. Sep 2016 A1
20170326341 Liska Nov 2017 A1
20180064912 Keyser et al. Mar 2018 A1
20180126125 Hall et al. May 2018 A1
20190038889 Keyser et al. Feb 2019 A1
20190060616 Solomon Feb 2019 A1
20190351210 Solomon et al. Nov 2019 A1
20200016375 Solomon Jan 2020 A1
20200061346 Solomon Feb 2020 A1
20200324088 Harding Oct 2020 A1
20210031009 Solomon Feb 2021 A1
20210268238 Solomon et al. Sep 2021 A1
20210290911 Hentzler et al. Sep 2021 A1
20220001146 Hentzler et al. Jan 2022 A1
20220280767 Solomon Sep 2022 A1
20220296859 Sutton Sep 2022 A1
Foreign Referenced Citations (20)
Number Date Country
203694357 Jul 2014 CN
316096 May 1989 EP
0653220 May 1995 EP
1291035 Mar 2003 EP
2655859 Jun 1991 FR
2687320 Aug 1993 FR
07-136285 May 1995 JP
09-047512 Feb 1997 JP
2007-260218 Oct 2007 JP
2011-234802 Nov 2011 JP
368422 Sep 1999 TW
592741 Jun 2004 TW
WO 1992016248 Oct 1992 WO
WO-9302734 Feb 1993 WO
WO-9830276 Jul 1998 WO
WO 2003013627 Feb 2003 WO
WO 2009091514 Jul 2009 WO
WO 2013119557 Aug 2013 WO
WO-2019046456 Mar 2019 WO
WO 2022178506 Aug 2022 WO
Provisional Applications (1)
Number Date Country
63367403 Jun 2022 US